A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 +- ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6.
BI-765049;Ezabenlimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 +- ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6. ### Output: BI-765049;Ezabenlimab